Air Particulate Matter Induces Skin Barrier Dysfunction and Water Transport Alteration on a Reconstructed Human Epidermis Model.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
12 2020
Historique:
received: 01 12 2018
revised: 24 03 2020
accepted: 31 03 2020
pubmed: 28 4 2020
medline: 2 4 2021
entrez: 28 4 2020
Statut: ppublish

Résumé

Knowing the damage that particulate matter (PM) can cause in skin is important for tightly controlling the release of air pollutants and preventing more serious diseases. This study investigates if such alterations are present in reconstructed human epidermis exposed to coarse air PM. Exposure of reconstructed human epidermis to increasing concentrations (2.2, 8.9, and 17.9 μg/cm

Identifiants

pubmed: 32339540
pii: S0022-202X(20)31403-2
doi: 10.1016/j.jid.2020.03.971
pii:
doi:

Substances chimiques

Air Pollutants 0
Biomarkers 0
FLG protein, human 0
Filaggrin Proteins 0
Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2343-2352.e3

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Daniele Seo Hieda (DS)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Larissa Anastacio da Costa Carvalho (L)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Barbara Vaz de Mello (B)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Erica Aparecida de Oliveira (EA)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Silvia Romano de Assis (S)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Joanna Wu (J)

Colgate-Palmolive Co, Piscataway, New Jersey, USA.

Laurence Du-Thumm (L)

Colgate-Palmolive Co, Piscataway, New Jersey, USA.

Claudia Larissa Viana da Silva (CL)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Deborah Arnsdorff Roubicek (DA)

CETESB - Companhia Ambiental do Estado de São Paulo, São Paulo, Brazil.

Silvya Stuchi Maria-Engler (SS)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Silvia Berlanga de Moraes Barros (S)

Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil. Electronic address: smbarros@usp.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH